Home > Publications > MGHI papers
MGHI papers
Metronomic metformin and propranolol combination prevents cancer progression and metastasis in breast cancer
María Rico, María Baglioni Maryna Bondarenko, Nahuel Cesatti Laluce, Viviana Rozados, Nicolas André, Manon Carré, O. Graciela Scharovsky, Mauricio Menacho Márquez from the Instituto de Genética Experimental, Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Rosario, Argentina, the CONICET, the Aix-Marseille Université, Inserm UMR_S 911,[...]
Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
Semin Cancer Biol. 2015 Sep 7. pii: S1044-579X(15)00075-9. doi: 10.1016/j.semcancer.2015.09.002.
Sébastien Benzekry, Eddy Pasquier, Dominique Barbolosi, Bruno Lacarelle, Fabrice Barlési, Nicolas André and Joseph Ciccolini from INRIA, Team MONC, Institut de mathématiques de Bordeaux UMR 5251, Université de Bordeaux, Talence, France; the Metronomics[...]
Metronomic Scheduling of Anticancer Agents for a Refractory Orbital Pseudotumor in a Child
This is a short report about the use of metronomic chemotherapy for a refractory orbital pseudo tumour, written by Pr Jamila Elhoudzi from Moroco and Nicolas André from MGHI.
Metronomic Scheduling of Anticancer Treatment The Next Generation Of Multitarget Therapy?
Future Oncology. 2011;7(3):385-394. © 2011 Future Medicine Ltd.
Metronomics — fulfilling unmet needs beyond level A evidence
We have just published in Nature Reviews Clinical Oncology a short piece about metronomic chemotherapy and drug repositioning entitled "Metronomics — fulfilling unmet needs beyond level A evidence" The 3 authors are MGHI members : Nicolas André, Shripad Banavali and Eddy Pasquier from the Inserm UMR_S 911, Centre de Recherche en Oncologie biologique et[...]
Metronomics : India showing the way !
As part of the metronomic special that has been released in the Indian Journal of Cancer, MGHI members Nicolas ANDRE and Eddy PASQUIER have written a short editorial commissioned by the editor of the journal where we try to pust in perspective the papers that have been published in thsi special issue.
You can have acces to the full text by clicking here.
Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch ?
In a recent opinion paper entitled : Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch published in Frontiers in Oncology
Prabhat S. Malik Vinod Raina and Nicolas André from the Metronomics Global Health Initiative, France , the Medical Oncology, All India Institute of Medical Sciences, the Medical Oncology, Fortis Memorial[...]
Metronomics chemotherapy: time for computational decision support.
A new article on metronomic chemotherapy has just been accepted for publication in Cancer Chemotherapy Pharmacology. The paper is entitled Metronomics chemotherapy: time for computational decision support and has been written by mathematicians, pharmacists, researchers and clinicians. It hilights the fact that computational pharmacology could help[...]
Metronomics during palliative care in paediatric oncology? For sure! But handle me with care
Following the article entitled Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential by Porkholm published in Acta Paediatr 2016 the editors have asked us to write an acompgnying short editorial piece.
Metronomic chemotherapy (MC) is low-dose chemotherapy that is[...]
Metronomics maintenance for HGNET-BCOR tumors of the cerebellum
In a recent article entitled : HGNET-BCOR Tumors of the Cerebellum Clinicopathologic and Molecular Characterization of 3 Cases by Romain Appay and al. in press in the American Journal of Surgical Pathology, the authors from the departments of Pathology and Neuropathology-Radiotherapy-Hematology & Pediatric Oncology-Pediatric Neurosurgery, Timone[...]
